NEKTAR THERAPEUTICS (NKTR) Stock Income Statement
NASDAQ:NKTR - Nasdaq - US6402681083 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 98.43M | 90.12M | 92.10M | 101.90M | 152.90M | |||
| Cost Of Goods | 30.69M | 33.77M | 21.60M | 24.90M | 19.50M | |||
| Gross Profit | 67.74M | 56.35M | 70.40M | 77.00M | 133.40M | |||
| Operating Expenses | 197.66M | 191.58M | 310.70M | 523.10M | 513.30M | |||
| Research and Development | 120.91M | 114.16M | 218.30M | 400.30M | 408.70M | |||
| Selling, General, and Administrative Expenses | 76.75M | 77.42M | 92.30M | 122.80M | 104.70M | |||
| Operating Income | -129.92M | -135.22M | -240.30M | -446.10M | -379.90M | |||
| Interest Income/Expense | -13.61M | -6.33M | 11.20M | -52.80M | -18.80M | |||
| Other Income/Expense | -390.00K | -6.25M | 0.00 | -24.40M | N/A | |||
| Non Recurring Items | 24.72M | -128.46M | -135.90M | 0.00 | -45.20M | |||
| Income Before Taxes | -119.20M | -276.26M | -365.00M | -523.30M | -443.90M | |||
| Income Tax | -239.00K | -200.00K | 3.20M | 600.00K | 500.00K | |||
| Net Income | -118.96M | -276.06M | -368.20M | -523.80M | -444.40M | |||
| EBITDA | -125.53M | -127.41M | -227.30M | -432.00M | -365.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.58 | -1.45 | -1.97 | -2.86 | -2.49 | |||
| Non GAAP EPS | -0.78 | -1.05 | -1.97 | -2.85 | -2.24 | |||
| Statistics | ||||||||
| Gross Profit Margin | 68.82% | 62.53% | 76.44% | 75.56% | 87.25% | |||
| Profit Margin | -120.86% | -306.31% | -399.78% | -514.03% | -290.65% | |||
| Operating Profit Margin | -131.99% | -150.05% | -260.91% | -437.78% | -248.46% | |||
All data in USD